ブトルファノールの市場：製品タイプ、用途、流通チャネル別-2025-2030年の世界予測

ブトルファノール市場は、2023年に2億7,147万米ドルと評価され、2024年には2億8,374万米ドルに達すると予測され、CAGR 4.30%で成長し、2030年には3億6,475万米ドルに達すると予測されています。

ブトルファノールは疼痛管理に使用されるオピオイド鎮痛薬であり、陣痛や手術時の疼痛緩和、他のオピオイド鎮痛薬に抵抗性のある患者の疼痛コントロールなど、ヘルスケア環境における様々な用途を包含しています。ブトルファノールの必要性は、中等度から重度の疼痛管理、特に代替薬が有効でない、あるいは適切でない場面での有効性にあります。その用途は、病院、手術センター、獣医学などのエンドユーザーにまで広がっています。市場の範囲には医薬品、ヘルスケア機関、動物病院が含まれ、多様な疼痛管理ニーズに対応するために安定した供給が求められています。

現在の市場分析では、慢性疼痛や手術関連処置の有病率の増加が主な成長要因として強調されており、ブトルファノールのような効果的な鎮痛薬に対する需要の高まりを後押ししています。さらに、ヘルスケア提供者の間で疼痛管理の選択肢に関する認識が高まっていることも、市場拡大を後押ししています。ブトルファノールの動物用アプリケーションを拡大し、家畜やペットに焦点を当て、強固な疼痛管理ソリューションが不足している新興市場に導入することで、潜在的なビジネスチャンスがあります。ヘルスケア機関や動物用医薬品企業との戦略的提携やパートナーシップは、市場のプレゼンスをさらに高める可能性があります。

しかし、市場は、特にオピオイド関連の規制や中毒・誤用のリスクに関する制限や課題に直面しており、これが成長の妨げとなる可能性があります。オピオイドを取り巻くネガティブなイメージは、規制ガイドラインの厳格な遵守を必要とし、市場浸透に影響を与える可能性があります。さらに、代替の非オピオイド鎮痛剤の出現は、ブトルファノールの需要を減退させる可能性があります。

イノベーションのためには、中毒性を抑えた製剤の開発や、有効性と安全性のプロファイルを最適化するデリバリーシステムの研究開発が必要です。また、そのユニークな薬理学的側面を強調することで、より広いオピオイド市場の中でニッチを切り開く可能性のある進歩がもたらされるかもしれないです。全体として、市場競争は依然激しいが有望であり、多様な用途や地域で成長余地があることから、ブトルファノールがもたらす機会を十分に活用するために、イノベーションと戦略的市場ポジショニングに注力することが示唆されます。

市場力学：急速に進化するブトルファノール市場の主要市場インサイトを公開

ブトルファノール市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ブトルファノールサプライチェーン・ロジスティクスに影響を及ぼす厳しい規制政策とガイドライン
  • ブトルファノールの動物用医薬品およびアニマルヘルスケア市場への応用拡大
  • 新薬開発のための製薬会社と研究機関の共同作業
  • 医療費の増加、疼痛管理の研究開発への投資の増加
• 市場抑制要因
  • 代替疼痛管理療法との市場競争によりブトルファノールの市場シェアが低下する可能性
  • ブトルファノールの合成および製造プロセスの高コストにより、市場全体の価格設定が上昇
• 市場機会
  • 先進地域における疼痛管理ソリューションとしてのブトルファノールの需要増加を探る
  • 動物用鎮痛剤としてのブトルファノールの動物医療における成長可能性の分析
  • ヘルスケアへのアクセスが増加している新興国におけるブトルファノールの市場拡大機会の調査
• 市場の課題
  • ブトルファノール市場拡大に影響する厳しい規制承認と高コストの制約
  • 新興市場における疼痛管理ソリューションとしてのブトルファノールの認知度と採用率の低さ

ポーターの5つの力：ブトルファノール市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ブトルファノール市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ブトルファノール市場における外部からの影響の把握

外部マクロ環境要因は、ブトルファノール市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ブトルファノール市場における競合情勢の把握

ブトルファノール市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスブトルファノール市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ブトルファノール市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ブトルファノール市場における成功への道筋を描く

ブトルファノール市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ブトルファノールサプライチェーン物流に影響を与える厳格な規制ポリシーとガイドライン
    • 獣医学および動物ヘルスケア市場におけるブトルファノールの応用拡大
    • 先端医薬品開発に向けた製薬企業と調査機関の連携
    • ヘルスケア費支出の増加と疼痛管理の研究開発への投資
  • 抑制要因
    • 代替疼痛管理療法との市場競争ブトルファノールの市場シェアが減少する可能性がある
    • ブトルファノール合成および製造プロセスの高コストにより、市場全体の価格が上昇する
  • 機会
    • 先進地域における疼痛管理ソリューションとしてのブトルファノールの需要増加の調査
    • 動物の鎮痛のための獣医学におけるブトルファノールの成長可能性を分析
    • ヘルスケアへのアクセスが拡大する新興国におけるブトルファノールの市場拡大機会の調査
  • 課題
    • ブトルファノールの市場拡大に影響を与える厳格な規制当局の承認と高コストの制約
    • 新興市場における疼痛管理ソリューションとしてのブトルファノールの認知度と採用は限られている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ブトルファノールの市場：製品タイプ別

• 注射
• 鼻スプレー

第7章 ブトルファノールの市場：用途別

• がんの痛み
• 陣痛
• 片頭痛の痛み
• 術後の痛み

第8章 ブトルファノールの市場：流通チャネル別

• オフライン
• オンライン

第9章 南北アメリカのブトルファノールの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のブトルファノールの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのブトルファノールの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Akorn, Inc.
• 2. Amneal Pharmaceuticals, Inc.
• 3. Aurobindo Pharma USA, Inc.
• 4. BioDelivery Sciences International, Inc.
• 5. Egalet Corporation
• 6. Endo Pharmaceuticals Inc.
• 7. Esteve Pharmaceuticals
• 8. Fresenius Kabi USA, LLC
• 9. Hikma Pharmaceuticals PLC
• 10. Hospira, Inc.
• 11. Johnson & Johnson
• 12. Lupin Pharmaceuticals, Inc.
• 13. Mallinckrodt Pharmaceuticals
• 14. Mylan N.V.
• 15. Novartis International AG
• 16. Pfizer Inc.
• 17. Purdue Pharma L.P.
• 18. Sanofi S.A.
• 19. Sun Pharmaceutical Industries Ltd.
• 20. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. BUTORPHANOL MARKET RESEARCH PROCESS
• FIGURE 2. BUTORPHANOL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BUTORPHANOL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BUTORPHANOL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BUTORPHANOL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BUTORPHANOL MARKET DYNAMICS
• TABLE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BUTORPHANOL MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BUTORPHANOL MARKET SIZE, BY LABOR PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BUTORPHANOL MARKET SIZE, BY MIGRAINE PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BUTORPHANOL MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BUTORPHANOL MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BUTORPHANOL MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 28. CANADA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. CHINA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 48. INDIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. ITALY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. POLAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. QATAR BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. BUTORPHANOL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. BUTORPHANOL MARKET, FPNV POSITIONING MATRIX, 2023

The Butorphanol Market was valued at USD 271.47 million in 2023, expected to reach USD 283.74 million in 2024, and is projected to grow at a CAGR of 4.30%, to USD 364.75 million by 2030.

Butorphanol is an opioid analgesic used for pain management, encompassing a variety of applications in healthcare settings, such as pain relief during labor or surgery and controlling pain in patients resistant to other opioid analgesics. The necessity of Butorphanol lies in its efficacy in managing moderate to severe pain, particularly in scenarios where alternatives may not be effective or suitable. Its application extends to end-users in hospitals, surgical centers, and veterinary medicine. The market scope includes pharmaceuticals, healthcare institutions, and veterinary practices, demanding consistent supply to address diverse pain management needs.

Current market insights emphasize the increasing prevalence of chronic pain conditions and surgery-related procedures as key growth influencers, driving heightened demand for effective analgesics like Butorphanol. Additionally, rising awareness regarding pain management options among healthcare providers bolsters market expansion. Potential opportunities lie in expanding the veterinary application of Butorphanol, focusing on livestock and pets, and introducing it into emerging markets lacking robust pain management solutions. Strategic collaborations and partnerships with healthcare institutions and veterinary pharmaceutical companies can further augment market presence.

However, the market faces limitations and challenges, especially concerning opioid-related regulations and the risk of addiction and misuse, which can hinder growth. The negative perception surrounding opioids necessitates stringent compliance with regulatory guidelines, possibly affecting market penetration. Furthermore, the advent of alternative non-opioid pain relievers may dampen Butorphanol's demand.

For innovation, research could focus on developing Butorphanol formulations with reduced addictive properties or delivery systems optimizing its efficacy and safety profile. Emphasizing its unique pharmacological aspects may also yield advancements, potentially carving out a niche within the broader opioid market. Overall, the market remains competitive but promising, with scope for growth in diversified applications and regions, suggesting a focus on innovation and strategic market positioning to fully leverage the opportunities Butorphanol presents.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Butorphanol Market

The Butorphanol Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Stringent regulatory policies and guidelines affecting the Butorphanol supply chain logistics
  • Expanding applications of Butorphanol in veterinary medicine and animal healthcare markets
  • Collaborative efforts between pharmaceutical companies and research institutions for advanced drug development
  • Increasing healthcare expenditure and investment in pain management research and development
• Market Restraints
  • Market competition from alternative pain management therapies may erode butorphanol's market share
  • High cost of butorphanol synthesis and production processes increases overall market pricing
• Market Opportunities
  • Exploring the rise in demand for Butorphanol as a pain management solution in developed regions
  • Analyzing the growth potential of Butorphanol in veterinary medicine for animal pain relief
  • Investigating the market expansion opportunities for Butorphanol in emerging countries with increasing healthcare access
• Market Challenges
  • Stringent regulatory approvals and high-cost constraints affecting butorphanol market expansion
  • Limited awareness and adoption of butorphanol as a pain management solution in emerging markets

Porter's Five Forces: A Strategic Tool for Navigating the Butorphanol Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Butorphanol Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Butorphanol Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Butorphanol Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Butorphanol Market

A detailed market share analysis in the Butorphanol Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Butorphanol Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Butorphanol Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Butorphanol Market

A strategic analysis of the Butorphanol Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Butorphanol Market, highlighting leading vendors and their innovative profiles. These include Akorn, Inc., Amneal Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., BioDelivery Sciences International, Inc., Egalet Corporation, Endo Pharmaceuticals Inc., Esteve Pharmaceuticals, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals PLC, Hospira, Inc., Johnson & Johnson, Lupin Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Mylan N.V., Novartis International AG, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Butorphanol Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Injection and Nasal Spray.
• Based on Application, market is studied across Cancer Pain, Labor Pain, Migraine Pain, and Postoperative Pain.
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Stringent regulatory policies and guidelines affecting the Butorphanol supply chain logistics
    • 5.1.1.2. Expanding applications of Butorphanol in veterinary medicine and animal healthcare markets
    • 5.1.1.3. Collaborative efforts between pharmaceutical companies and research institutions for advanced drug development
    • 5.1.1.4. Increasing healthcare expenditure and investment in pain management research and development
  • 5.1.2. Restraints
    • 5.1.2.1. Market competition from alternative pain management therapies may erode butorphanol's market share
    • 5.1.2.2. High cost of butorphanol synthesis and production processes increases overall market pricing
  • 5.1.3. Opportunities
    • 5.1.3.1. Exploring the rise in demand for Butorphanol as a pain management solution in developed regions
    • 5.1.3.2. Analyzing the growth potential of Butorphanol in veterinary medicine for animal pain relief
    • 5.1.3.3. Investigating the market expansion opportunities for Butorphanol in emerging countries with increasing healthcare access
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory approvals and high-cost constraints affecting butorphanol market expansion
    • 5.1.4.2. Limited awareness and adoption of butorphanol as a pain management solution in emerging markets
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Butorphanol Market, by Product Type

• 6.1. Introduction
• 6.2. Injection
• 6.3. Nasal Spray

7. Butorphanol Market, by Application

• 7.1. Introduction
• 7.2. Cancer Pain
• 7.3. Labor Pain
• 7.4. Migraine Pain
• 7.5. Postoperative Pain

8. Butorphanol Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Offline
• 8.3. Online

9. Americas Butorphanol Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Butorphanol Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Butorphanol Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Akorn, Inc.
• 2. Amneal Pharmaceuticals, Inc.
• 3. Aurobindo Pharma USA, Inc.
• 4. BioDelivery Sciences International, Inc.
• 5. Egalet Corporation
• 6. Endo Pharmaceuticals Inc.
• 7. Esteve Pharmaceuticals
• 8. Fresenius Kabi USA, LLC
• 9. Hikma Pharmaceuticals PLC
• 10. Hospira, Inc.
• 11. Johnson & Johnson
• 12. Lupin Pharmaceuticals, Inc.
• 13. Mallinckrodt Pharmaceuticals
• 14. Mylan N.V.
• 15. Novartis International AG
• 16. Pfizer Inc.
• 17. Purdue Pharma L.P.
• 18. Sanofi S.A.
• 19. Sun Pharmaceutical Industries Ltd.
• 20. Teva Pharmaceutical Industries Ltd.